JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.57B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
AbbVie
ABBV
|
+$1.02B |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$827M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.43B |
| 2 |
Amazon
AMZN
|
+$1.85B |
| 3 |
Cigna
CI
|
+$1.16B |
| 4 |
Microsoft
MSFT
|
+$1.08B |
| 5 |
Morgan Stanley
MS
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.67% |
| 2 | Technology | 15.47% |
| 3 | Financials | 11.13% |
| 4 | Healthcare | 9.58% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Northrop Grumman
NOC
$67.3B
| $1.78B | 0.22% |
4,943,070
+462,349
| +10% | +$167M |
2013 Q2
33 quarters
|
|
102
iShares US Treasury Bond ETF
GOVT
$41.3B
| $1.77B | 0.22% |
66,830,793
-19,393,478
| -22% | -$519M |
2015 Q4
23 quarters
|
|
103
ASML
ASML
$693B
| $1.77B | 0.22% |
2,369,986
-235,532
| -9% | -$185M |
2013 Q2
33 quarters
|
|
104
Schwab Short-Term US Treasury ETF
SCHO
$15.3B
| $1.76B | 0.22% |
68,856,938
+929,928
| +1% | +$23.8M |
2019 Q4
7 quarters
|
|
105
Dover
DOV
$25.4B
| $1.75B | 0.22% |
11,253,104
-924,856
| -8% | -$153M |
2013 Q2
33 quarters
|
|
106
Alibaba
BABA
$266B
| $1.75B | 0.22% |
11,803,202
-857,232
| -7% | -$156M |
2014 Q3
28 quarters
|
|
107
Snap
SNAP
$9.83B
| $1.74B | 0.22% |
23,535,588
-11,660,230
| -33% | -$842M |
2017 Q1
18 quarters
|
|
108
S&P Global
SPGI
$116B
| $1.73B | 0.21% |
4,063,600
+298,834
| +8% | +$129M |
2016 Q2
21 quarters
|
|
109
CVS Health
CVS
$112B
| $1.71B | 0.21% |
20,179,811
+2,162,463
| +12% | +$181M |
2013 Q2
33 quarters
|
|
110
AutoZone
AZO
$46B
| $1.69B | 0.21% |
995,344
-94,039
| -9% | -$151M |
2013 Q2
33 quarters
|
|
111
Zimmer Biomet
ZBH
$16.9B
| $1.69B | 0.21% |
11,878,105
+2,473,695
| +26% | +$364M |
2013 Q2
33 quarters
|
|
112
T. Rowe Price
TROW
$22.2B
| $1.65B | 0.2% |
8,393,559
-134,370
| -2% | -$28.3M |
2013 Q2
33 quarters
|
|
113
State Street Industrial Select Sector SPDR ETF
XLI
$30B
| $1.64B | 0.2% |
16,736,984
+1,731,500
| +12% | +$178M |
2013 Q2
33 quarters
|
|
114
DexCom
DXCM
$31.8B
| $1.64B | 0.2% |
11,973,140
-3,020,880
| -20% | -$381M |
2015 Q3
24 quarters
|
|
115
Vanguard Total Bond Market
BND
$158B
| $1.62B | 0.2% |
19,001,710
+260,737
| +1% | +$22.5M |
2013 Q2
33 quarters
|
|
116
EOG Resources
EOG
$75.6B
| $1.62B | 0.2% |
20,214,000
+246,277
| +1% | +$17.9M |
2013 Q2
33 quarters
|
|
117
Boston Scientific
BSX
$60.3B
| $1.62B | 0.2% |
37,387,665
-2,181,758
| -6% | -$96.5M |
2013 Q2
33 quarters
|
|
118
Chubb
CB
$129B
| $1.62B | 0.2% |
9,309,903
+220,131
| +2% | +$38.6M |
2013 Q2
33 quarters
|
|
119
Biogen
BIIB
$32.8B
| $1.59B | 0.2% |
5,605,297
+250,531
| +5% | +$82.1M |
2013 Q2
33 quarters
|
|
120
iShares 1-3 Year Treasury Bond ETF
SHY
$26.3B
| $1.58B | 0.2% |
18,397,133
+4,564,605
| +33% | +$394M |
2013 Q2
33 quarters
|
|
121
Mondelez International
MDLZ
$75.8B
| $1.58B | 0.2% |
27,149,977
-104,668
| -0.4% | -$6.51M |
2013 Q2
33 quarters
|
|
122
Stanley Black & Decker
SWK
$13.3B
| $1.57B | 0.19% |
8,960,044
-1,732,612
| -16% | -$338M |
2013 Q2
33 quarters
|
|
123
TJX Companies
TJX
$153B
| $1.57B | 0.19% |
23,799,819
+425,235
| +2% | +$29.7M |
2013 Q2
33 quarters
|
|
124
CME Group
CME
$97.2B
| $1.57B | 0.19% |
8,104,068
-133,027
| -2% | -$27M |
2013 Q2
33 quarters
|
|
125
Linde
LIN
$223B
| $1.56B | 0.19% |
5,320,463
-831,604
| -14% | -$253M |
2018 Q4
11 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2021 Portfolio in Review
As of Q3 2021, JP Morgan Chase held 7,104 positions worth $809B, down 3.5% from $838B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2021 filing shows 647 new, 2,077 increased, 3,085 reduced and 500 closed positions. Its largest new stake was Toast: 2,760,295 shares worth $138M. The largest sale was Apple, an estimated $2.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2021 buy was Toast: 2,760,295 shares worth $138M.
- JP Morgan Chase added most to Vanguard Short-Term Bond ETF in Q3 2021, an estimated $5.57B increase.
- JP Morgan Chase's biggest Q3 2021 reduction was Apple, cutting an estimated $2.43B.
- JP Morgan Chase fully exited Weingarten Realty Investors in Q3 2021, selling an estimated $401M.
- JP Morgan Chase's ten largest holdings make up 16% of its $809B portfolio in Q3 2021.
- JP Morgan Chase opened 647 new positions and closed 500 in Q3 2021.
- JP Morgan Chase's portfolio value fell 3.5% quarter-over-quarter to $809B.
Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.